Pinealon
Also known as: Pinealon tripeptide
Pinealon is a synthetic tripeptide developed in Russia and studied for reported neuroprotective and cognitive effects. It is a research peptide and is not approved for human use.
- Category
- Cognitive / Nootropic
- Reported half-life
- Not well established
- Common forms
- Lyophilised powder for reconstitution, Oral capsule (research bioregulator preparations)
- Research status
- Studied in Russia as a peptide bioregulator; not approved for human use in Australia or other major jurisdictions. Independent human clinical evidence is very limited.
- Last updated
- 21 June 2026
Claimed effects
The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.
- Reported in animal research to have neuroprotective effects
- Studied for possible effects on cognition and oxidative stress
- Reported to influence gene expression in neural tissue (a proposed peptide bioregulator action)
- Reported to interact with neuronal repair processes
How it is reported to work
Pinealon is a short synthetic peptide (often described as Glu-Asp-Arg) belonging to a class of 'peptide bioregulators' studied in Russia. It is proposed to penetrate cells and influence gene expression and antioxidant responses in neural tissue. These proposed mechanisms come from animal and laboratory studies and remain preliminary and unconfirmed in humans.
Background
Pinealon is a synthetic short peptide studied in Russia as part of a group of so-called peptide bioregulators. It has been investigated mainly for reported neuroprotective properties. This page is educational information, not medical advice, and the effects below are reported claims, not established facts.
What the research shows
Published Pinealon research consists largely of animal and laboratory studies from a limited number of research groups. These suggest possible neuroprotective and antioxidant-related effects, but the evidence is preliminary and not confirmed in robust human clinical trials.
| Evidence type | Status |
|---|---|
| Animal / laboratory studies | Present |
| Independent human trials | Lacking |
| Australian approval | None |
What people use it for (reported)
Online, some people report interest in Pinealon for cognition and “anti-ageing” of the brain. These are anecdotal reports without clinical validation. Reported benefits should not be read as proven, and nothing here is encouragement to use it.
Things to be aware of
Pinealon is not approved for human use in Australia, and independent human safety data are minimal. Grey-market preparations cannot be verified for purity or identity. If you have a cognitive or neurological concern, the appropriate step is to consult a qualified healthcare professional. This article does not recommend obtaining or using Pinealon.
Reported positives & side effects
Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.
Reported positives
- Reported in animal research to have neuroprotective effects
- Reported interest in supporting cognition and reducing oxidative stress
- Reported to influence neural gene expression as a proposed bioregulator action
- Reported subjective clarity or calm by some users
Common side effects
- Injection-site irritation reported with reconstituted forms
- Headache reported by some users
- Fatigue or drowsiness reported
- Mild gastrointestinal upset reported with oral preparations
Rare / serious side effects
- Allergic or hypersensitivity reactions reported
- Unknown long-term effects given minimal independent human data
- Unverified effects from contaminated grey-market product
Reported misuse & overdose risks
What has been reported to happen with overuse, excessive dosing, or long-term misuse of Pinealon. Listed so you can make an informed decision, not to suggest any use is safe.
- Reported human self-experimentation despite very limited independent human safety data
- Reported use of unverified grey-market bioregulator product with uncertain identity and purity
- Reported dosing or course lengths beyond those described in Russian research
- Reported stacking with multiple peptide bioregulators without monitoring
Reported results timeline
Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Reported subjective effects are described over days to a few weeks, though independent human evidence confirming any onset is very limited.
First effects
Reported subtle alertness or calm within days
Noticeable change
Reported cognitive or mood shifts over one to two weeks
Clear results
Reported cumulative effects over a short course, though unconfirmed in humans
Commonly reported dosing & protocol
Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take Pinealon. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.
| Route | Subcutaneous injection |
|---|---|
| Typical reported dose | Reported as roughly 100-300 mcg per day |
| Frequency | Reported as once daily during a course |
| Cycle length | Reported in short courses of a few weeks, sometimes repeated periodically; not standardised |
Reported reconstitution (mg → units)
A 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL. A 200 mcg (0.2 mg) dose is about 0.04 mL = 4 units on a U-100 insulin syringe.
Work out the units for your vial → CalculatorCommonly reported as short courses of daily dosing (oral or reconstituted) over a few weeks, sometimes repeated periodically; reported patterns vary. This is reported information, not advice.
Best used with / commonly stacked with
Combinations people report using together. Reported, not recommended, stacking can increase risks.
Safety notes
Pinealon is not approved for human use in Australia and has minimal independent human safety data. Grey-market preparations cannot be verified for identity or purity by consumers. Anyone with a health concern should consult a qualified healthcare professional rather than self-experiment.